Arryn Craney

Affiliations: 
2012- Scripps Research Institute, La Jolla, La Jolla, CA, United States 
Google:
"Arryn Craney"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Walsh SI, Peters DS, Smith PA, et al. (2018) The inhibition of protein secretion in and sub-MIC effects of arylomycin antibiotics. Antimicrobial Agents and Chemotherapy
Yeh CH, Walsh SI, Craney A, et al. (2018) Optimization of a β-Lactam Scaffold for Antibacterial Activity via the Inhibition of Bacterial Type I Signal Peptidase. Acs Medicinal Chemistry Letters. 9: 376-380
Craney A, Romesberg FE. (2017) Stable Signal Peptides and the Response to Secretion Stress in Staphylococcus aureus. Mbio. 8
Romesberg FE, Craney A. (2016) Discovery of novel antibacterials. Bioorganic & Medicinal Chemistry. 24: 6225-6226
Walsh SI, Craney A, Romesberg FE. (2016) Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence. Bioorganic & Medicinal Chemistry
Craney A, Dix MM, Adhikary R, et al. (2015) An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus. Mbio. 6
Craney A, Romesberg FE. (2015) The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential. Bioorganic & Medicinal Chemistry Letters. 25: 4761-6
Craney A, Romesberg FE. (2015) A Putative Cro-Like Repressor Contributes to Arylomycin Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 59: 3066-74
Jani C, Tocheva EI, McAuley S, et al. (2015) Streptomyces: a screening tool for bacterial cell division inhibitors. Journal of Biomolecular Screening. 20: 275-84
Craney A, Romesberg FE. (2015) The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential Bioorganic and Medicinal Chemistry Letters
See more...